The oversubscribed round will scale up manufacturing and research for the bioactive protein developer.
Qkine
Qkine manufactures specialist bioactive proteins for stem cell and regenerative medicine applications.
Qkine develops and manufactures animal-free bioactive proteins and growth factors for stem cell research, regenerative medicine and cellular agriculture applications.
Filed accounts
Cash at bank
Net current assets
Total assets less current liabilities
Net assets
Shareholders' funds
Fixed assets
Cash, assets and headcount from Qkine's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders

Marko Hyvönen
Co-Founder and CSO
Marko serves as a Research Group Head at the University of Cambridge and co-founded Qkine, where he acts as chief scientific officer. He also holds a visiting professorship at the Universidade de São Paulo.
LinkedInCatherine Elton
CEO and Founder
Catherine founded Qkine and held research roles at the Wellcome Trust Sanger Institute. She currently serves as chief business officer at Axol Bioscience and non-executive director at Atelerix.
LinkedInInvestors
- £4.3M
- £1.5M
Funding history
Parkwalk led the series A round with participation from life science investors and angels to fund international expansion and senior hires.



